This wiki has undergone a migration to Confluence found Here

Reviewable Unit (RPS)

From HL7Wiki
Revision as of 22:31, 10 November 2008 by Joelfinkle (talk | contribs) (→‎Human Pharmaceuticals)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

This is a Glossary page

This page is under discussion and definitions and aligmnent with the BRIDG model have not yet been finalized

R1 Working Definition

Collection of one or more Submission Units groupted together (usually by subject) that collectively become part of a Submission for purpose of review. [not fully discussed]

ICH Equivalent



Reviewable Unit (???)

A discrete portion of a submission which is used to receive agreement. Once agreement is reached on all units within the submission the submission can then be approved.

For example, in a Modular pre-marketing application (PMA) several modules will be sent to the Food & Drug Administration (FDA). Each module will be agreed upon independently of other modules. The FDA then approves the submission based on compilation of all of the modules. These modules are reviewable units.

For example, a veterinary medicine New Animal Drug Application (NADA) (marketing application) is constructed from the Investigational New Animal Drug Application (INADA). In the INADA process the sponsor creates reviewable units. These reviewable units are then compiled to be used as documentation for the marketing application.

Additional Regional Definitions and Synonyms

Human Pharmaceuticals


  • Similar to "teishutsu": A collection of structured documents provided to the regulatory authority at one time. Each submission unit has a sequence number unique in that Submission/Application.


No equivalent concepts have been found in other countries and regions


United States

  • Modules in a Modular PMA